ClinicaliQ Trial Snapshot
- Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation — Recruiting • Gastroenterology • NCT03193151.
- What is being tested: INTERLIVER evaluates whether microarray analysis of liver transplant biopsies can identify molecular patterns that correlate with histological findings and predict clinical outcomes, potentially improving diagnostic accuracy beyond standard histopathology alone.
- Patient eligibility overview: The study includes 300 liver transplant recipients undergoing clinically indicated biopsies for standard-of-care diagnostic purposes, with biopsy segments retained for molecular microarray analysis alongside routine histological assessment.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Eligibility Snapshot
- : * biopsy for clinical indications
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.